| 其他| 1. | 趙珮瑩(2006)。人工靜脈輸液植入器化學藥物外滲的處理。 延伸查詢 | | 2. | ADAPTE(2007)。ADAPTE framework.。  | | 3. | Agency for Healthcare Research and Quality (AHRQ).(2000)。Agency for healthcare research and quality.。 | | 4. | Cancer Care Ontario (CCO).(2006)。Managing central venous access devices in cancer patients: A clinical practice guideline members of the central venous access device.。 | | 5. | Dorr, R. T., Snead, K., & Liddil, J. D.(1996)。Skin ulceration of paclitaxel in a mouse skin model in vivo.。 | | 6. | Ener, R. A., Meglathery, S. B., & Styler, M.(2004)。Extravasation of systemic hemato-oncological therapies.。 | | 7. | Fenchl, K., & Karthaus, M.(2000)。Cytoxic drug extravasation.。 | | 8. | Goolsby, T. V., & Lombardo, F. A.(2006)。Extravasation of chemotherapeutic agents: Pre vention and treatment。 | | 9. | Gowan, D. M., & Wood, S.(2008)。Developing a venous assessment tool in IV chemotherapy administration.。 | | 10. | Graham, I. D., & Harrison, M. B.(2005)。Evaluation and adaptation of clinical practice guidelines.。 | | 11. | Jones, L., & Coe, P.(2004)。Extravasation。 | | 12. | Langestein, H. N., Duman, H., & Seelig, D.(2002)。Retrospective study of the management of chemotherapeutic extravasation injury.。 | | 13. | National Extravasation Information Service (NEIS).(2004)。What is extravazation?。 | | 14. | National Health Service (NHS).(2007)。Guidelines for the management of extravasation.。 | | 15. | Oncology Nursing Society(2004)。Access device guidelines: Recommendations for nursing practice and education。 | | 16. | Polovich, M., White, J., & Kelleher, L.(2005)。Chemotherapy and biotherapy guidelines and recommendations for practice。 | | 17. | Registered Nurses’ Association of Ontario (RNAO).(2004)。Assessment and device selection for vascular access.。 | | 18. | Sauerland, C., Engelking, C., Wickham, R., & Corbi, D.(2006)。Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.。 | | 19. | Schrijvers, D. L.(2003)。Extravasation: A dreaded complication of chemotherapy.。 | | 20. | Schulmeister, L.(2007)。Extravasation management.。 | | 21. | Schulmeister, L.(2008)。Chemotherapy extravasation.。 | | 22. | Schulmeister, L.(2011)。Extravasation management: Clinical update.。 | | 23. | Schulmeister, L., & Camp-Sorrell, D.(2000)。Chemotherapy extravasation from implanted ports.。 | | 24. | Schummer, W., Schummer, C., Bayer, O., Muller, A., Bredle, D., & Karzai, W.(2005)。Extravasation injury in the perioperative setting.。 | | 25. | Sonneveld, P., Wassenaar, H. A., & Nooter, K.(1984)。Long persistence of doxorubicin in human skin after extravasation.。 | | 26. | Wengstrm, Y., & Margulies, A.(2008)。European Oncology Nursing Society extravasation guidelines.。 | | 27. | Wick, M. R., & Adams, R. K.(2007)。Medical malpractice actions: Procedural elements.。 | | 28. | Wickham, R., Engelking, C., Sauerland, C., & Corbi, D.(2006)。Vesicant extravasation part II: Evidence- based management and continuing controversies.。 | |